Ondine Biomedical Inc.
OBIMF
$0.11
-$0.02-15.39%
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -2.84M | -2.88M | -2.39M | -2.43M | -2.94M |
| Total Depreciation and Amortization | 103.80K | 105.30K | 103.60K | 105.10K | 113.50K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 137.00K | 139.10K | -16.90K | -17.10K | 192.10K |
| Change in Net Operating Assets | 6.90K | 7.00K | 292.90K | 297.10K | -407.60K |
| Cash from Operations | -2.59M | -2.63M | -2.01M | -2.04M | -3.04M |
| Capital Expenditure | -3.70K | -3.70K | -1.10K | -1.10K | -64.80K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -3.70K | -3.70K | -1.10K | -1.10K | -64.80K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -112.00K | -112.00K | -108.00K | -108.00K | -105.50K |
| Issuance of Common Stock | 3.03M | 3.03M | 2.46M | 2.46M | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -275.00K | -275.00K | -350.00K | -350.00K | -- |
| Cash from Financing | 1.93M | 1.96M | 1.47M | 1.49M | -78.50K |
| Foreign Exchange rate Adjustments | 15.00K | 15.20K | 14.00K | 14.20K | -47.30K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -646.00K | -655.70K | -532.20K | -539.80K | -3.23M |
